Véronique Maes

1.7k total citations
47 papers, 1.4k citations indexed

About

Véronique Maes is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Véronique Maes has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Véronique Maes's work include Radiopharmaceutical Chemistry and Applications (14 papers), Peptidase Inhibition and Analysis (9 papers) and Neuroendocrine Tumor Research Advances (9 papers). Véronique Maes is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Peptidase Inhibition and Analysis (9 papers) and Neuroendocrine Tumor Research Advances (9 papers). Véronique Maes collaborates with scholars based in Belgium, Switzerland and United States. Véronique Maes's co-authors include Dirk Tourwé, Roger Schibli, Luc Brans, Christian Schweinsberg, Peter Bläuenstein, Elisa Garcı́a Garayoa, P. August Schubiger, Harriet Struthers, Thomas L. Mindt and Elisa García‐Garayoa and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Clinical Chemistry.

In The Last Decade

Véronique Maes

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Maes Belgium 19 559 481 385 273 188 47 1.4k
Ronald D. Schoenwald United States 25 223 0.4× 233 0.5× 651 1.7× 157 0.6× 62 0.3× 74 2.3k
Nicolas Tournier France 24 235 0.4× 672 1.4× 300 0.8× 38 0.1× 179 1.0× 108 1.7k
Veli‐Pekka Ranta Finland 23 366 0.7× 142 0.3× 650 1.7× 45 0.2× 63 0.3× 64 1.8k
Armand Frydman France 23 44 0.1× 196 0.4× 279 0.7× 261 1.0× 36 0.2× 42 1.7k
John R. Jacobsen United States 22 107 0.2× 50 0.1× 652 1.7× 333 1.2× 33 0.2× 51 1.6k
Peter R. Gwilt United States 17 114 0.2× 207 0.4× 229 0.6× 26 0.1× 23 0.1× 44 963
Takuya Ikeda Japan 22 58 0.1× 100 0.2× 393 1.0× 250 0.9× 163 0.9× 99 1.2k
Frits Moolenaar Netherlands 21 38 0.1× 194 0.4× 425 1.1× 74 0.3× 43 0.2× 68 1.3k
William J. Daily United States 16 66 0.1× 84 0.2× 447 1.2× 72 0.3× 114 0.6× 34 1.2k
Guido Zimmer Germany 23 72 0.1× 212 0.4× 806 2.1× 117 0.4× 84 0.4× 107 1.9k

Countries citing papers authored by Véronique Maes

Since Specialization
Citations

This map shows the geographic impact of Véronique Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Maes more than expected).

Fields of papers citing papers by Véronique Maes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Maes. The network helps show where Véronique Maes may publish in the future.

Co-authorship network of co-authors of Véronique Maes

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Maes. A scholar is included among the top collaborators of Véronique Maes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Maes. Véronique Maes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salaklang, Jatuporn, et al.. (2017). Direct synthesis of acrylate monomers in heterogeneous continuous flow processes. Reaction Chemistry & Engineering. 3(1). 41–47. 8 indexed citations
2.
Müller, Cristina, Elisa Garcı́a Garayoa, Peter Bläuenstein, et al.. (2012). PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues. EJNMMI Research. 2(1). 24–24. 16 indexed citations
3.
Garayoa, Elisa Garcı́a, Véronique Maes, Luc Brans, et al.. (2011). PEGylation of 99mTc-labeled bombesin analogues improves their pharmacokinetic properties. Nuclear Medicine and Biology. 38(7). 997–1009. 34 indexed citations
4.
Hueting, Rebekka, Martin Christlieb, Jonathan R. Dilworth, et al.. (2010). Bis(thiosemicarbazones) as bifunctional chelators for the room temperature 64-copper labeling of peptides. Dalton Transactions. 39(15). 3620–3620. 42 indexed citations
5.
Brans, Luc, Elisa García‐Garayoa, Christian Schweinsberg, et al.. (2010). Synthesis and Evaluation of Bombesin Analogues Conjugated to Two Different Triazolyl‐Derived Chelators for 99mTc Labeling. ChemMedChem. 5(10). 1717–1725. 14 indexed citations
6.
Schweinsberg, Christian, Véronique Maes, Luc Brans, et al.. (2008). Novel Glycated [99mTc(CO)3]-Labeled Bombesin Analogues for Improved Targeting of Gastrin-Releasing Peptide Receptor-Positive Tumors. Bioconjugate Chemistry. 19(12). 2432–2439. 61 indexed citations
7.
Brans, Luc, Véronique Maes, Elisa García‐Garayoa, et al.. (2008). Glycation Methods for Bombesin Analogs Containing the (NαHis)Ac chelator for 99mTc(CO)3 Radiolabeling. Chemical Biology & Drug Design. 72(6). 496–506. 13 indexed citations
8.
Maes, Véronique & Dirk Tourwé. (2007). Double targeting of prostate cancer xenografts with radiolabeled neurotensin and bombesin analogues. VUBIR (Vrije Universiteit Brussel). 181–181. 1 indexed citations
9.
Maes, Véronique, et al.. (2006). Fluorescein-labeled stable neurotensin derivatives. Journal of Peptide Science. 12(8). 505–508. 7 indexed citations
10.
García‐Garayoa, Elisa, Véronique Maes, Peter Bläuenstein, et al.. (2006). Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. Nuclear Medicine and Biology. 33(4). 495–503. 40 indexed citations
11.
Fernández, María del Mar Ramírez, et al.. (2005). Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of 26 Benzodiazepines and Metabolites, Zolpidem and Zopiclone, in Blood, Urine, and Hair. Journal of Analytical Toxicology. 29(7). 616–626. 103 indexed citations
12.
Lheureux, Philippe, et al.. (2001). Cobas Mira  S Endpoint Enzymatic Assay for Plasma Formate. Journal of Analytical Toxicology. 25(2). 77–80. 7 indexed citations
13.
Verstraete, Alain & Véronique Maes. (2000). The elaboration of the new 'per se' legislation on drugs and driving in Belgium. 2000. 5 indexed citations
14.
Maes, Véronique, et al.. (1999). Orphenadrine poisoning in a child: clinical and analytical data. Intensive Care Medicine. 25(10). 1134–1136. 9 indexed citations
15.
Hachimi-Idrissi, Saı̈d, et al.. (1996). Gitaloxin poisoning in a child. Intensive Care Medicine. 22(12). 1442–1444. 1 indexed citations
16.
Claeys, M. A., F. Camu, & Véronique Maes. (1992). Prophylactic diclofenac infusions in major orthopedic surgery: effects on analgesia and acute phase proteins. Acta Anaesthesiologica Scandinavica. 36(3). 270–275. 28 indexed citations
18.
Michotte, Alex, et al.. (1989). Ataxia as the Only Delayed Neurotoxic Manifestation of Organophosphate Insecticide Poisoning. European Neurology. 29(1). 23–26. 14 indexed citations
19.
Gepts, E., et al.. (1988). Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia. 43(s1). 8–13. 76 indexed citations
20.
Eeckhout, E., Luc Huyghens, Bert G. Loef, Véronique Maes, & J. Sennesael. (1988). Meprobamate poisoning, hypotension and the swan-ganz catheter. Intensive Care Medicine. 14(4). 437–438. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026